If you’ve ever tried to make an NMN gummy, you probably ran into a wall faster than you expected. It sounds easy enough-mix the powder into a sweet base, pour it into molds, and you’re done. But anyone who’s spent time inside a real cGMP facility knows the truth: NMN gummies are one of the most technically stubborn products you can manufacture. The problem isn’t the ingredient itself. It’s the environment you’re asking it to live in.
Let’s talk about what happens inside that gummy. No health claims. No hype. Just the physics and chemistry that determine whether your product will hold up on the shelf-or fall apart before it ever reaches a customer.
Why NMN and gummies don’t naturally get along
NMN, or Nicotinamide Mononucleotide, is a nucleotide sugar. In manufacturing terms, that means two things: it’s hygroscopic-it grabs moisture out of the air-and it’s thermally labile-heat degrades it quickly.
Now consider what a standard gummy requires. You start with a wet slurry of gelatin or pectin, heat it to somewhere between 140°F and 190°F, then pour it into molds. The final gummy has a water activity (Aw) between 0.5 and 0.7. That’s basically a warm, wet, slightly acidic sponge.
For NMN, that’s hostile territory. High moisture triggers hydrolysis. High heat accelerates breakdown. And if you’re using a pectin base-common for vegetarian gummies-you’re working at a pH around 3.0 to 4.0. NMN is most stable at neutral pH. Drop it into acid, and it starts converting to other forms, changing the molecular profile of your finished product.
So right from the start, you’ve got a fundamental conflict baked into the process.
The “easy fix” that doesn’t pass cGMP
Some manufacturers try to dodge the problem entirely by dusting NMN powder onto the outside of finished gummies. This keeps the ingredient away from heat and water during cooking. But from a regulatory standpoint, it’s a mess.
When you spray or dust powder onto a moving line of sticky gummies, you cannot guarantee uniform dosing. One gummy might get 200 mg, the next only 100 mg. Under 21 CFR 111, finished products must be within ±10% of the label claim for potency. Dusting simply cannot meet that standard.
At KorNutra, we don’t use that method. Instead, we treat NMN like the sensitive raw material it is and build the manufacturing protocol around its limitations.
How we actually make a stable NMN gummy
Our approach uses a two-phase process designed to protect the NMN from the environment it has to live inside.
- Phase 1: The anhydrous pre-mix. We never dissolve NMN directly into the water phase of the gummy. Instead, we create a non-aqueous suspension using a GRAS carrier-typically glycerin or an oil-based medium with near-zero water activity. This physically separates the NMN molecules from water during the early mixing stages.
- Phase 2: Late-stage injection at lower temperature. We cool the main gummy mass-whether gelatin or pectin-to below 130°F before we introduce the NMN pre-mix. Using high-shear emulsification, we micro-disperse the NMN droplets throughout the matrix. Each molecule becomes a tiny island surrounded by a protective barrier, minimizing contact with the acidic, watery gel.
What does that get us? We consistently see >90% NMN retention after cook. The industry standard for direct powder addition often falls between 60% and 70%. And because we inject a liquid suspension mechanically, every gummy gets the same dose, batch after batch.
Regulatory boundaries you can’t ignore
This part matters a lot. Under current FDA guidance, we cannot put any statement on your label that implies NMN “boosts NAD+” or “slows aging.” Those are drug claims. We can list “Nicotinamide Mononucleotide 150 mg” on the Supplement Facts panel. We can structure the product as a dietary supplement. But the label and marketing must stay within structure-function limits.
Also, because NMN is a high-potency, low-dosage ingredient, we run full cGMP testing on every batch: heavy metals, microbial, and potency. If a gummy has less NMN than claimed due to thermal degradation during manufacturing, that’s a regulatory violation. Our stability data is designed to prevent that.
The bottom line
An NMN gummy is not a commodity. It’s a precision-engineered dosage form that demands respect for the raw material’s chemistry. If you want a simple, cheap gummy, pick another ingredient. But if you want a stable, compliant, high-quality NMN gummy that meets label claims and passes regulatory scrutiny, the manufacturing process has to be built around the molecule-not the other way around.
At KorNutra, we don’t just mix ingredients. We design the environment around them. That’s the difference between a gummy that works on paper and one that actually works on the shelf.
Ready to dig into the technical details? Contact our formulation team. We’ll share the stability data. No hype. Just the facts you need to make an informed decision.